Diese Präsentation wurde erfolgreich gemeldet.
Die SlideShare-Präsentation wird heruntergeladen. ×

LUNG CANCER MICRO TEACHING.pptx

Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Anzeige
Nächste SlideShare
Lung tumor
Lung tumor
Wird geladen in …3
×

Hier ansehen

1 von 24 Anzeige

Weitere Verwandte Inhalte

Anzeige

Aktuellste (20)

LUNG CANCER MICRO TEACHING.pptx

  1. 1. VIVEKANANDA COLLEGE OF NURSING MICRO-TEACHING PRESENTED BY- APURVA DWIVEDI [M.Sc. Nsg. 1ST Yr.]
  2. 2. LUNG CANCER
  3. 3. INTRODUCTION ◦ A lung tumor is an abnormal rate of cell division or cell death in lung tissue or in the airways that lead to the lungs. ◦ Lung tumor is a type of cancer that begins in the lungs. The lungs are two spongy organs in your chest that take in oxygen when you inhale and release carbon dioxide when you exhale.
  4. 4. DEFINITION ◦ A benign lung tumor is an abnormal growth of tissue that serves no purpose and is found not to be cancerous. Benign lung tumor may grow from many different structures in the lung.
  5. 5. RISK FACTORS: ◦ Smoking: The risk of lung cancer increases with the number of cigarettes you smoke each day and the number of years you have smoked. Quitting at any age can significantly lower your risk of developing lung cancer. ◦ Exposure to secondhand smoke: Even if you don't smoke, your risk of lung cancer increases if you're exposed to secondhand smoke.
  6. 6. CONTI. ◦ Previous radiation therapy: If you've undergone radiation therapy to the chest for another type of cancer, you may have an increased risk of developing lung cancer. ◦ Exposure to asbestos and other carcinogens: Workplace exposure to asbestos and other substances known to cause cancer — such as arsenic, chromium and nickel — can increase your risk of developing lung cancer, especially if you're a smoker.
  7. 7. CONTI. ◦ Family history of lung cancer: People with a parent, sibling or child with lung cancer have an increased risk of the disease
  8. 8. ETIOLOGY: ◦ Cigarette smoking which contain 43 known chemical carcinogens & ca promoters is most significant cause of ca. ◦ Genetic abnormality chromosome 3 with loss of genetic material. ◦ Alteration of tumor suppressor gene.
  9. 9. PATHOPHYSIOLOGY: Due to etiological factors Damage of bronchial epithelial cells Mutation of bronchial epithelial cells Epithelial cells become neoplastic
  10. 10. TYPES OF LUNG CANCER
  11. 11. CLINICAL MANIFESTATION: ◦ Cough that doesn't go away ◦ Coughing up blood, even a small amount ◦ Shortness of breath ◦ Chest pain ◦ Hoarseness ◦ Losing weight without trying ◦ Bone pain ◦ Headache
  12. 12. DIAGNOSTIC EVALUATION: ◦ Chest x-ray: usually provide the Ist evidence of lung cancer. It may be used as a screening tool for lung ca. ◦ Sputum specimen: is sent for cytologic examination. The sputum sample is collected on arising in the morning. If malignant cells are found in the sputum more invasive examinations are required. ◦ Bronchoscopy: done to visualize & obtain tissue for biopsy from the tumor.
  13. 13. CONTI. ◦ CT-scan: it is used to evaluate & localize tumors in the lung parenchyma & pleura. CT scanning can also detect distant tumor metastasis & evaluate tumor response to treatment. ◦ Cytologic examination: cells or tissues for cytologic examination & biopsy may be obtained by aspirating fluid from a pleural effusion, percutaneous needle biopsy & lymph node biopsy.
  14. 14. CONTI. ◦ CBC, liver function test & serum electrolytes: Including ca are obtained to evaluate for evidence of metastatic disease or paraneoplstic syndromes. ◦ Tuberculin test is performed to rule out TB as a cause of symptoms. ◦ Pulmonary function test: may be performed prior to the initiation of treatment if the client has manifestations of respiratory insufficiency (e.g. dyspnea, low oxygen saturation level).
  15. 15. MANAGEMENT: Chemotherapy: Used in combination, chemotherapeutic drugs to be attached at different parts of the cell cycle & in different ways, increasing the effectiveness of therapy. Chemotherapy drugs that commonly used are- Vance Alkaloids (Vinblastine), Doxorubicin, Taxanes (Docetaxel), Plantin analogus (Cisplantin, & Carboplantin).
  16. 16. CONTI. ◦Radiation therapy It is used alone or in combination with surgery & chemotherapy.
  17. 17. SURGICAL MANAGEMENT
  18. 18. ◦ Lasser bronchoscopy ◦ Mediastinoscopy ◦ Thoracotomy ◦ Bronchial Sleeve resection
  19. 19. COMPLICATION ◦ Shortness of breath: People with lung cancer can experience shortness of breath if cancer grows to block the major airways. ◦ Coughing up blood: Lung cancer can cause bleeding in the airway, which can cause you to cough up blood (hemoptysis). ◦ Pain: Advanced lung cancer that spreads to the lining of a lung or to another area of the body, such as a bone, can cause pain.
  20. 20. Conti. ◦ Fluid in the chest (pleural effusion) Lung cancer can cause fluid to accumulate in the space that surrounds the affected lung in the chest cavity (pleural space). Fluid accumulating in the chest can cause shortness of breath. ◦ Cancer that spreads to other parts of the body (metastasis).
  21. 21. Nursing management: ◦ Assessing fluid and electrolyte status. ◦ Assessing cognitive status. ◦ Modifying risks for infection and bleeding. ◦ Administer chemotherapy. ◦ Prevent nausea and vomiting. ◦ Managing cognitive changes. ◦ Manage fatigue. ◦ Provide psychological support.
  22. 22. Nursing diagnosis: ◦ Ineffective breathing pattern r/t tumor & treatment of tumor. ◦ Activity intolerance r/t resectional lung surgery & inoperable lung ca. ◦ Acute pain r/t surgical procedure or terminal stage of ca. ◦ Anticipatory grieving r/t advanced diagnosis of lung ca.
  23. 23. THANK YOU..

×